MX9101682A - COMPOUNDS EQUIVALENT TO LIVING SKIN. - Google Patents

COMPOUNDS EQUIVALENT TO LIVING SKIN.

Info

Publication number
MX9101682A
MX9101682A MX9101682A MX9101682A MX9101682A MX 9101682 A MX9101682 A MX 9101682A MX 9101682 A MX9101682 A MX 9101682A MX 9101682 A MX9101682 A MX 9101682A MX 9101682 A MX9101682 A MX 9101682A
Authority
MX
Mexico
Prior art keywords
skin
equivalent
collagen
layer
well
Prior art date
Application number
MX9101682A
Other languages
Spanish (es)
Inventor
Mark Eisenberg
Original Assignee
Mark Eisenberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark Eisenberg filed Critical Mark Eisenberg
Priority to MX9101682A priority Critical patent/MX9101682A/en
Publication of MX9101682A publication Critical patent/MX9101682A/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

se describe un compuesto equivalente a la piel viva que comprende una capa epidérmica de células cultivadas queratinociticas, una capa de colágeno no poroso, y una capa dérmica de células fibroblasticas cultivadas en una matriz de esponga de colágeno de enlace cruzado porosa. Preferentemente el colágeno no poroso es colágeno bovino del tipo 1, tipo 3 o mezcla de los tipos 1 y 3, el cual ha sido tratado con pepsina. Se describe un proceso para preparar el equivalente de piel, así como un equipo de prueba para la prueba in vitro del equivalente de la piel. El equivalente de piel tiene aplicación para injertos de piel así como para las pruebas in vitro de los efectos de varias substancias en la piel.We describe a compound equivalent to living skin comprising an epidermal layer of cultured keratinocytic cells, a layer of nonporous collagen, and a dermal layer of fibroblastic cells grown in a matrix of porous cross-link collagen sponge. Preferably the non-porous collagen is bovine collagen type 1, type 3 or mixture of types 1 and 3, which has been treated with pepsin. A process for preparing the skin equivalent is described, as well as a test kit for in vitro testing of the skin equivalent. The skin equivalent has application for skin grafts as well as for in vitro testing of the effects of various substances on the skin.

MX9101682A 1991-10-21 1991-10-21 COMPOUNDS EQUIVALENT TO LIVING SKIN. MX9101682A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9101682A MX9101682A (en) 1991-10-21 1991-10-21 COMPOUNDS EQUIVALENT TO LIVING SKIN.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9101682A MX9101682A (en) 1991-10-21 1991-10-21 COMPOUNDS EQUIVALENT TO LIVING SKIN.

Publications (1)

Publication Number Publication Date
MX9101682A true MX9101682A (en) 1994-06-30

Family

ID=19743400

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101682A MX9101682A (en) 1991-10-21 1991-10-21 COMPOUNDS EQUIVALENT TO LIVING SKIN.

Country Status (1)

Country Link
MX (1) MX9101682A (en)

Similar Documents

Publication Publication Date Title
KINIKOGLU et al. Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering
CA2080693A1 (en) Composite living skin equivalents
Bell et al. Development and use of a living skin equivalent
BR0210599A (en) Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium
Chick Brief history and biology of skin grafting
DK1545565T3 (en) Compositions containing mitotically inactivated allogeneic fibroblasts and keratinocytes for use in tissue regeneration
DE69630129D1 (en) USE OF AUTOLOGOLOGY, DERMAL FIBROBLASTS TO REPAIR SKIN OR SOFT TISSUE DAMAGES
DE69532976D1 (en) METHOD OF PRODUCING FABRICS FOR IMPLANTATION
ATE384782T1 (en) RECONSTRUCTION OF ORGANS FROM A DECELLULARIZED BIOLOGICAL SCAFFOLD
ES2071292T3 (en) STABLE INJECTABLE FACTOR SOLUTIONS VIII.
Valencia et al. Skin grafting
ES2075011T3 (en) USE OF GAMMA-HYDROXYBUTRIC ACID SALTS TO PREPARE PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF ALCOHOLISM, AND THE COMPOSITIONS OBTAINED.
DK0549774T3 (en) Use of porous calcium carbonate as carrier material for in vitro cell cultures
ATE399563T1 (en) EXTRACELLULAR MATRIX CONTAINING GDF-5 FOR INDUCING OR ENHANCEMENT OF CHONDROGENESIS
DE60106056D1 (en) Collagen membrane with macromolecular arrangement
ES2102984T3 (en) MEANS FOR CELL GROWTH AND PROCEDURE TO PREPARE THEM.
ES2132399T3 (en) STIMULATING COMPOSITION OF OSTEOBLASTOS GROWTH CONTAINING PDGF AND VITAMIN D.
DE69721021D1 (en) BUBBLE MUKOSA WITH CELLS FOR TISSUE RECONSTRUCTION
Fimiani et al. Other uses of homologous skin grafts and skin bank bioproducts
Yamada et al. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing
MX9101682A (en) COMPOUNDS EQUIVALENT TO LIVING SKIN.
Eisinger Regeneration of epidermis by cells grown in tissue culture
ES2482765T3 (en) Müller stem cells
DE69528473T2 (en) USE OF HEPATOCYTE GROWTH FACTOR FOR INDUCING PROLIFERATION AND DIFFERENTIATION OF HEMATOPOIETIC CELLS
Hannen et al. Skin tissue engineering and keratinocyte stem cell therapy